![]() ![]() The safety of flu vaccines is monitored by CDC and FDA. Hundreds of millions of Americans have safely received flu vaccines for more than 50 years and the body of scientific evidence overwhelmingly supports their safety. In some cases, the healthcare provider may decide to postpone influenza vaccination to a future visit or suggest a different influenza vaccine.įindings from vaccine safety monitoring systems and scientific studies have shown that the flu vaccines have an excellent safety profile. People who are moderately or severely ill should usually wait until they recover before getting a flu vaccine. Have had Guillain-Barré Syndrome after a previous dose of influenza vaccine.Have moderate or severe acute illness with or without fever.These include conditions such as chronic lung diseases, heart disease (except isolated hypertension), kidney disease, liver disorders, neurologic and neuromuscular disorders, blood disorders, or metabolic disorders (such as diabetes). Have other underlying medical conditions that can put them at high risk of developing serious flu complications.People should talk to their healthcare provider before getting a nasal spray flu vaccine if they: (See Prevention and Control of Seasonal Influenza with Vaccines – ACIP Recommendations for a list of contraindications and precautions for the nasal spray vaccine.) LAIV is not recommended for people with some kinds of chronic health conditions because the safety and effectiveness of this vaccine in people with those conditions has not been established.People who have taken these medications should talk with their healthcare provider about which influenza antiviral was taken, and when the last dose was taken. Have recently taken influenza antiviral drugs.Are 2 years through 4 years and have asthma or have had a history of wheezing in the past 12 months.Care for or are close contacts of severely immunocompromised persons who require a protected environment (or otherwise avoid contact with those persons for 7 days after getting the nasal spray vaccine).Have weakened immune systems (immunosuppression).Are between 2-17 years of age and are receiving aspirin, aspirin-containing, or salicylate-containing products.Have severe, life-threatening allergies to nasal spray flu vaccine or any ingredient in the vaccine.People should not get a nasal spray flu vaccine if they: ![]() This is the only cell-based inactivated influenza vaccine that has been licensed by the FDA for using during the 2021-2022 flu season.įlublok Quadrivalent : FDA approved this recombinant vaccine for use in persons 18 years of age and older.įluzone Quadrivalent : FDA approved this vaccine for use in persons 6 months of age and older. This is the only LAIV nasal spray vaccine available for use during the 2021-2022 season.įluarix Quadrivalent : FDA approved this vaccine for use in persons 6 months of age and older.įlucelvax Quadrivalent : FDA approved this vaccine for use in persons aged 2 years and older. Afluria Quadrivalent : The Food and Drug Administration (FDA) approved this vaccine for use in persons 6 months of age and older.įluLaval Quadrivalent : FDA approved this vaccine for use in persons 6 months of age and older.įluMist Quadrivalent : FDA approved this live attenuated influenza virus (LAIV) nasal spray vaccine for persons 2 through 49 years of age.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |